Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-19 4:53 pm Purchase | 2025-09-17 | 13D | Vor Biopharma Inc. VOR | RA CAPITAL MANAGEMENT L.P. | 1,988,657 29.000% | 1,988,657 (New Position) | Filing History |
| 2025-09-19 4:47 pm Purchase | 2025-09-12 | 13G | LB PHARMACEUTICALS INC LBRX | RA CAPITAL MANAGEMENT L.P. | 1,675,000 7.500% | 1,675,000 (New Position) | Filing History |
| 2025-09-08 6:00 pm Purchase | 2025-09-04 | 13D | Mineralys Therapeutics, Inc. MLYS | RA CAPITAL MANAGEMENT L.P. | 7,796,433 9.900% | 1,508,836 (+24.00%) | Filing History |
| 2025-08-29 4:32 pm Purchase | 2025-08-22 | 13G | Invivyd, Inc. IVVD | RA CAPITAL MANAGEMENT L.P. | 21,338,288 9.900% | 21,338,288 (New Position) | Filing History |
| 2025-08-26 4:59 pm Purchase | 2025-06-30 | 13G | Adagio Medical Holdings, Inc. ADGM | RA CAPITAL MANAGEMENT L.P. | 1,200,000 7.200% | 1,200,000 (New Position) | Filing History |
| 2025-08-20 4:41 pm Purchase | 2025-06-30 | 13G | CervoMed Inc. CRVO | RA CAPITAL MANAGEMENT L.P. | 1,026,937 9.900% | 1,026,937 (New Position) | Filing History |
| 2025-08-18 5:52 pm Purchase | 2025-08-11 | 13G | Assembly Biosciences, Inc. ASMB | RA CAPITAL MANAGEMENT L.P. | 1,530,615 9.500% | 1,530,615 (New Position) | Filing History |
| 2025-08-14 6:14 pm Sale | 2025-06-30 | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT L.P. | 593,670 0.700% | -5,417,442 (-90.12%) | Filing History |
| 2025-08-14 6:13 pm Sale | 2025-06-30 | 13G | UroGen Pharma Ltd. URGN | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,206,271 (Position Closed) | Filing History |
| 2025-08-14 6:11 pm Purchase | 2025-06-30 | 13G | Taysha Gene Therapies, Inc. TSHA | RA CAPITAL MANAGEMENT L.P. | 25,345,988 9.900% | 3,806,523 (+17.67%) | Filing History |
| 2025-08-14 6:10 pm Sale | 2025-06-30 | 13G | Sutro Biopharma, Inc. STRO | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -4,434,637 (Position Closed) | Filing History |
| 2025-08-14 6:08 pm Sale | 2025-06-30 | 13G | Sera Prognostics, Inc. SERA | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,032,808 (Position Closed) | Filing History |
| 2025-08-14 6:06 pm Purchase | 2025-08-12 | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT L.P. | 7,997,510 9.900% | 7,997,510 (New Position) | Filing History |
| 2025-08-14 6:04 pm Sale | 2025-06-30 | 13G | Rhythm Pharmaceuticals, Inc. RYTM | RA CAPITAL MANAGEMENT L.P. | 5,561,359 8.700% | -523,053 (-8.60%) | Filing History |
| 2025-08-14 6:03 pm Sale | 2025-06-30 | 13G | Protara Therapeutics, Inc. TARA | RA CAPITAL MANAGEMENT L.P. | 1,971,765 4.900% | -1,459,948 (-42.54%) | Filing History |
| 2025-08-14 6:01 pm Purchase | 2025-06-30 | 13G | GH Research PLC GHRS | RA CAPITAL MANAGEMENT L.P. | 7,676,697 12.400% | 732,049 (+10.54%) | Filing History |
| 2025-08-14 6:00 pm Sale | 2025-06-30 | 13G | Day One Biopharmaceuticals, Inc. DAWN | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -5,755,577 (Position Closed) | Filing History |
| 2025-08-14 5:58 pm Sale | 2025-06-30 | 13G | CervoMed Inc. CRVO | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -916,063 (Position Closed) | Filing History |
| 2025-08-14 5:57 pm Sale | 2025-06-30 | 13G | Boundless Bio, Inc. BOLD | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,180,631 (Position Closed) | Filing History |
| 2025-08-14 5:56 pm Sale | 2025-06-30 | 13G | Astria Therapeutics, Inc. ATXS | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -5,105,213 (Position Closed) | Filing History |